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ABSTRACT 
 
Von Frey is used to quantify evoked allodynia in pain models for analgesic screening but is 
susceptible to false positives. This research explored whether behavior in a novel arena apparatus with a 
varied rough-textured floors in ½ fields might quantify spontaneous tactile allodynia and show better 
predictive validity. Mice (C57BL/6) received 6 IP administrations of 2.3mg/kg of cisplatin over 12 days to 
induce neuropathy (CIN). Behavioral measures were taken by eVF (g force to evoked stimuli) and arena 
apparatus (movement and time in ½ fields) prior to and following ClN induction, and then 1-day later 30 
min after each of 3 drug exposures (Saline, 3 mg/kg Oxycodone, and 100 mg/kg Gabapentin, IP) in a 
Latin Square Design with 1-2 day drug holiday between testing. In eVF testing, cisplatin produced an 
allodynic response that was attenuated by both oxycodone and gabapentin. In the arena apparatus, 
cisplatin produced a reduction in overall movement that was attenuated only by oxycodone. Cisplatin 
produced an increase in time spent on the 60 grit ½ field, but overall drug probes had inconsistent 
effects on time spent on ½ field. In clinical populations, CIN is effectively treated with oxycodone but 
not gabapentin. This novel arena apparatus, with a more translationally relevant spontaneous allodynia 
endpoint, shows better predictive validity than eVF and may be useful in identifying novel 
pharmacotherapies in oncology settings. 
 
 
INTRODUCTION & BACKGROUND 
 
Pain research relies on evoked 
behavioral endpoints, such as those 
measured by von Frey (VF), to quantify 
allodynia in various chronic pain models 
for analgesic screening but is susceptible 
to false positives. False positives occur 
when an animal assay predicts clinical 
efficacy but the drug fails in clinical trials. 
Such poor translational relevance may 
reflect animal models/behavioral 
endpoints that do not fully replicate 
features of a clinical syndrome. This may 
be particularly true with endpoints of 
allodynia where its clinical presentation 
is spontaneously evoked through normal 
activity. This research explored whether 
the behaviors of overall movement and 
time spent in ½ fields in a novel tactile 
arena apparatus with varied rough-
textured floors might quantify 
spontaneous tactile allodynia and show 
better predictive validity in a model of 
cisplatin-induced neuropathy (CIN). 
 
MATERIAL & METHODS 
 
Mice (C57BL/6) received 6 IP 
administrations of 2.3mg/kg of cisplatin 
over 12 days to induce neuropathy (CIN). 
Behavioral measures were taken by 
Topcat, MouseMet electronic-VF in g 
force to an evoked stimuli and by Noldus 
Ethovision overall movement and time 
spent in ½ fields in an arena apparatus 
containing 60 and 220 grit sandpaper in 
each ½ fields (see below). These 
endpoints were taken prior to and 
following ClN induction and then 30 min 
after each of 3 drug exposures (Saline, 3 
mg/kg Oxycodone, and 100 mg/kg 
Gabapentin, IP) in a Latin Square Design 
with a 1-2 day drug holiday between 
testing. Sample sizes were n = 12-14. 
per group. 
 
 
 
 
RESULTS
 
 
 
FIGURE 1. eVF: Cisplatin produced significant allodynia (†) that was significantly 
attenuated (*) by both oxycodone and gabapentin on test sessions 2 and 3 (ps < 
0.005).  
 
 
 
 
FIGURE 2. Arena-Movement: Cisplatin produced significant decrease in movement (†) 
that was significantly attenuated (*) by oxycodone and (**) gabapentin on test session 
1 but only by oxycodone on test session 2 (ps < 0.005).  
 
 
 
 
FIGURE 3. Arena-Time on ½ Field: Cisplatin produced a significant increase in spent 
time in the 60-grit ½ field (*) that was significantly attenuated (†)only by gabapentin 
on test session 1 (ps < 0.005).  
 
 
 
 
 
DISCUSSION & CONCLUSION 
 
In clinical populations, CIN is 
effectively treated with oxycodone but 
not gabapentin. This research found 
that evoked responses from eVF were 
sensitive to oxycodone and gabapentin 
in attenuating allodynia induced by 
CIN and, thus, susceptible to false 
positives. The novel tactile arena was 
most sensitive to oxycodone and only 
modestly sensitive to gabapentin on 
movement and only sensitive to 
gabapentin on time in ½ field. This 
tactile arena using changes in 
movement may provide a more 
translationally relevant measure of 
allodynia than eVF. These findings 
suggest this novel apparatus may be 
useful in identifying novel analgesic 
pharmacotherapies in oncology 
settings.  
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